Scott Montgomery is the Group CEO of i-screen, a preventive health technology platform operating across Australia, Singapore, New Zealand, and the United Kingdom. Under his leadership, i-screen has grown to serve over 145,000 users and delivered more than 1.1 million diagnostic tests, building one of the most comprehensive longitudinal multi-omic datasets in the Asia-Pacific region, spanning blood biomarkers, genomics, microbiome, and metabolomics.

Scott leads i-screen's evolution from a direct-to-consumer testing business into an AI-powered health intelligence platform, integrating wearable data, digital vitals, and continuous glucose monitoring with traditional pathology to deliver personalised, preventive health insights at scale. His work sits at the intersection of clinical diagnostics, artificial intelligence, and consumer health technology.

Based in Singapore, Scott oversees i-screen's expansion across four regulated markets and its partnerships with major wearable technology companies, practitioner networks spanning 4,000+ providers in Southeast Asia, and laboratory partners including the Eurofins network. He is passionate about shifting healthcare from reactive treatment to predictive prevention, using multi-omic data and AI to give individuals earlier, more actionable insight into their health trajectory.